Venn Life Sciences Holdings (VENN)

 

VENN Share PerformanceMore

52 week high29.385 05/09/16
52 week low13.000 20/07/17
52 week change -15.250 (-52.59%)
4 week volume476,431 26/07/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Senior Management Appointment

Notification of any change to a company’s board e.g. appointments/resignations/changes to important functions or executive responsibilities of a director

Venn Life Sciences reports strong start to 2017

Venn Life Sciences announced the new financial year started well with contract wins of 5.7m secured in January and Feb...

Half year end update

Statement regarding a company’s trading performance (e.g. profit warning)

Result of AGM

Notification of the result of any voting at an AGM

Proposed amendment to AGM resolution

Miscellaneous medium priority announcements

Integumen IPO

Miscellaneous medium priority announcements

Enterprise Securities Market Notice

Annual Financial Report & Notice of AGM

Publication of a company's annual financial report

Equity Research (VENN)

Venn Life Sciences Holdings plc
09/08/2017
Last week saw the acquisition of Aptuit by Evotec (EVT.DE) for $300m. This is against forecasted revenues 2017 of €100m to €110m a multiple of circa 2.4x (forward) and adjusted EBITDA in 2016 of €...
Venn Life Sciences Holdings plc
04/08/2017
Venn Life Sciences* (VENN.L) 13.75p £8.29m* The growing Contract Research Organisation providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology...
Venn Life Sciences Holdings plc
25/07/2017
The growing Contract Research Organisation providing drug development, clinical trial management and resourcing solutions to pharmaceuticals, biotechnology and medical device clients today announced...

Latest discussion posts More

  • VENN very, very cheap against sector

    Interesting new note out from Hybridan a couple of weeks ago. This pointed out that Evotec's recent acquisition of Aptuit was on a multiple of 2.4 times revenues, and on 23 ...
    21-Aug-2017
    gretel
  • New Hybridan note

    Hybridan brought out a new note on Thursday envisaging a 30p+ share price on delivery of 2017 forecasts (against the current 13.75p). Their forecasts are: this year : ...
    24-Jul-2017
    gretel
  • Decent H1 trading statement

    Pretty good H1 trading statement, in particular expressing confidence going forward. Note the ?2.9m cash against the #9m ...
    20-Jul-2017
    gretel

Users' HoldingsMore

Users who hold Venn Life Sciences Holdings also hold..
APC TECHNOLOGY22%
AMINO TECH22%
REDSTONECON16%
ROCKHOPPER16%
21ST CENT TECH11%

Codes & Symbols

ISINGB00B9275X97
SymbolsVENN, LSE:VENN, VENN.L, VENN:LN, LON:VENN, XLON:VENN